- 全部删除
您的购物车当前为空
β2AR agonist 4 (compound A19) 是一种选择性β2-肾上腺素受体 (β2-Adrenoceptor) 激动剂,具有3.7 pM的EC50。在COPD大鼠模型中,β2AR agonist 4 可抑制炎症因子和白细胞的上调,同时改善肺功能。
β2AR agonist 4 (compound A19) 是一种选择性β2-肾上腺素受体 (β2-Adrenoceptor) 激动剂,具有3.7 pM的EC50。在COPD大鼠模型中,β2AR agonist 4 可抑制炎症因子和白细胞的上调,同时改善肺功能。

β2AR agonist 4 相关产品
| 产品描述 | β2AR agonist 4 (compound A19) is an effective selective agonist for the β2-adrenoceptor (β2-Adrenoceptor), exhibiting an EC50 of 3.7 pM. In a rat model with COPD, β2AR agonist 4 reduces the elevation of inflammatory factors and leukocytes, thereby improving lung function. |
| 分子式 | C19H23ClN2O5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容